{"gene":"CD48","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1995,"finding":"The CD2-binding site on rat CD48 lies on the equivalent GFCC'C\" beta-sheet of its membrane-distal immunoglobulin domain. Complementary mutations showed that two charged residues in CD48's ligand-binding site interact directly with two oppositely charged residues in CD2's ligand-binding site, establishing a head-to-head topology for the CD2-CD48 complex that spans approximately 134 Å.","method":"Complementary mutagenesis of CD2 and CD48 extracellular domains; structural modeling","journal":"Current Biology","confidence":"High","confidence_rationale":"Tier 1 — direct mutagenesis of binding interface with reciprocal charge-swap validation; structural modelling corroborated by crystal lattice data","pmids":["7697352"],"is_preprint":false},{"year":1996,"finding":"Single-molecule force measurements between surface-attached rat CD2 and CD48 showed that arrests were generated by single molecular bonds with an initial bond dissociation rate of ~7.8 s⁻¹, consistent with surface plasmon resonance affinity constants of ~10⁴ M⁻¹ and a weak, rapidly dissociating interaction.","method":"Flow chamber single-bond kinetics; surface plasmon resonance","journal":"Proceedings of the National Academy of Sciences USA","confidence":"High","confidence_rationale":"Tier 1 — direct biophysical measurement at single-molecule level, corroborated by independent SPR","pmids":["8986773"],"is_preprint":false},{"year":1997,"finding":"Analytical ultracentrifugation (sedimentation equilibrium and velocity) of soluble recombinant rat CD2 and CD48 extracellular domains in free solution yielded dissociation constants of 20–110 µM, confirming the weak affinity of the CD2-CD48 interaction without artefacts from surface immobilisation.","method":"Analytical ultracentrifugation (sedimentation equilibrium and velocity)","journal":"European Biophysics Journal","confidence":"High","confidence_rationale":"Tier 1 — three independent ultracentrifugation methods in free solution, corroborating SPR data","pmids":["9188168"],"is_preprint":false},{"year":1998,"finding":"2B4 was identified as a novel counter-receptor (ligand) for murine CD48 by immunofluorescence and immunoprecipitation experiments using a chimeric CD48-IgG1 fusion protein.","method":"CD48-IgG1 fusion protein binding assay; immunofluorescence; immunoprecipitation","journal":"Journal of Immunology","confidence":"High","confidence_rationale":"Tier 1/2 — fusion protein pulldown combined with immunoprecipitation; foundational receptor-ligand identification paper","pmids":["9834056"],"is_preprint":false},{"year":1998,"finding":"Engagement of GPI-linked CD48 on T cells by CD2 expressed on APCs enhances TCR-mediated signaling by qualitatively and quantitatively increasing lipid raft-dependent association of the TCR zeta chain with the actin cytoskeleton and zeta tyrosine phosphorylation, implicating lipid rafts as integration platforms for receptor signals and cytoskeletal reorganization.","method":"T cell:APC co-stimulation assay; lipid raft fractionation; actin cytoskeleton co-sedimentation; zeta chain phosphorylation analysis","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal biochemical methods in one study with clear functional readout","pmids":["9881969"],"is_preprint":false},{"year":1998,"finding":"CD48 expressed on antigen-presenting cells (CHO transfectants) enhances murine CD4+ T cell proliferation and IL-2 production in an antigen-specific manner, and this effect is mediated through CD2:CD48 interaction as shown by anti-CD2 mAb blockade; CD48 also increases T cell–APC conjugate formation.","method":"CHO transfectant co-stimulation assay; T cell proliferation; IL-2 ELISA; conjugate assay; blocking mAb","journal":"European Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 — clean transfectant system with multiple functional readouts, single lab","pmids":["9862369"],"is_preprint":false},{"year":1999,"finding":"Human 2B4 (NAIL/CD244) binds CD48 with high affinity as determined by soluble NAIL-Fc fusion protein; engagement of CD48 by recombinant CD48 protein increases NK cell cytotoxicity and induces IFN-γ production, and 2B4 ligation on human NK cells by CD48 or specific mAb triggers NK-mediated cytotoxicity.","method":"Soluble fusion protein binding assay; NK cytotoxicity assay; IFN-γ measurement; mAb ligation","journal":"European Journal of Immunology","confidence":"High","confidence_rationale":"Tier 1/2 — molecular binding assay plus multiple functional NK cell readouts, independently consistent with other 2B4/CD48 papers","pmids":["10359122","10556801"],"is_preprint":false},{"year":1999,"finding":"CD48-deficient mice generated by gene targeting show severely impaired CD4+ T cell activation (reduced proliferative responses to mitogens, anti-CD3 mAb, and alloantigen), demonstrating that CD48 is important on both T cells and antigen-presenting cells for T cell receptor signaling.","method":"Gene targeting (knockout mice); T cell proliferation assay; mixed lymphocyte reaction; mitogen stimulation; phorbol ester co-stimulation","journal":"Proceedings of the National Academy of Sciences USA","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple activation readouts and reciprocal cell-mixing experiments","pmids":["9927686"],"is_preprint":false},{"year":2000,"finding":"CD48 co-localises and co-clusters with IL-2Rα and HLA molecules in cholesterol-rich lipid raft microdomains (~600–800 nm) on human T lymphoma cells, and disruption of membrane cholesterol with filipin or methyl-β-cyclodextrin disperses these clusters, establishing that CD48 resides in and requires intact lipid rafts for its membrane organisation.","method":"Immunogold electron microscopy; confocal microscopy; cholesterol depletion (filipin, methyl-β-cyclodextrin); cross-correlation analysis","journal":"Proceedings of the National Academy of Sciences USA","confidence":"High","confidence_rationale":"Tier 1/2 — two orthogonal imaging methods with cholesterol depletion functional validation","pmids":["10823948"],"is_preprint":false},{"year":2001,"finding":"2B4/CD48 interactions regulate CD8+ T cell proliferation; blocking with anti-2B4 antibody reduces proliferative responses, and this occurs even in the absence of APCs, indicating that 2B4 on activated/memory T cells can serve as a ligand for CD48 on neighboring T cells to provide costimulatory-like function.","method":"Anti-2B4 and anti-CD48 blocking antibodies; T cell proliferation assay; APC-free cultures","journal":"Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 3 — antibody blocking with clear functional readout; single lab but mechanistically informative","pmids":["11739483"],"is_preprint":false},{"year":2002,"finding":"Direct force measurements confirmed that full-length extracellular domains of murine CD2 and CD48 adhere in a head-to-head orientation, that the CD2-CD48 bond generates weak adhesion, and that lateral receptor mobility is required for appreciable adhesion.","method":"Surface force apparatus (direct force measurements between protein-coated surfaces)","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro biophysical reconstitution directly measuring interaction distance-dependence and adhesion forces","pmids":["12356317"],"is_preprint":false},{"year":2003,"finding":"CD48 on mast cells mediates direct interaction with Mycobacterium tuberculosis: CD48 aggregates at sites of bacterial binding, and anti-CD48 antibodies inhibit mast cell histamine release in response to mycobacteria, indicating CD48 functions as a pattern recognition receptor for mycobacterial binding.","method":"Immunofluorescence microscopy (CD48 aggregation at bacterial binding sites); anti-CD48 antibody blockade; histamine release assay","journal":"Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 3 — localization with functional blockade, single lab","pmids":["12759438"],"is_preprint":false},{"year":2005,"finding":"Homotypic 2B4/CD48 interactions among NK cells are essential for IL-2-driven NK cell expansion and activation; in the absence of 2B4/CD48 interaction (using gene-deficient cells and mAbs), NK cytotoxicity, IFN-γ secretion, and calcium signaling are severely impaired, and GFP-tagged 2B4 localises specifically to NK-NK conjugation sites.","method":"2B4-deficient NK cells; blocking mAbs; cytotoxicity assay; IFN-γ ELISA; calcium flux; GFP-2B4 live imaging of NK-NK conjugates; in vivo tumor clearance","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — gene-deficient cells combined with live imaging and multiple functional readouts in vitro and in vivo","pmids":["15905190"],"is_preprint":false},{"year":2005,"finding":"CD48 expression on dendritic cell subsets determines NK cell activation outcomes: monocyte-derived DCs and plasmacytoid DCs lack CD48, whereas blood/bone marrow myeloid DCs express it; NK cells are activated by CD48-expressing DCs but inhibited via 2B4 by CD48-expressing lymph node DCs, demonstrating that DC-subset-specific CD48 expression tunes 2B4-mediated NK activation or inhibition depending on anatomic context.","method":"Flow cytometry; NK:DC co-culture functional assays; IFN-γ production; NK cells from XLP patients (lacking SAP)","journal":"Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 — correlative expression combined with functional NK:DC co-culture assays including disease-validated (XLP) NK cells","pmids":["16148114"],"is_preprint":false},{"year":2005,"finding":"CD48 interacts with IL-18Rα via both the peptide portion and the GPI glycan; IL-18Rα co-immunoprecipitates with CD48 from IL-18-stimulated KG-1 cells. Phospholipase C treatment removing GPI-anchored proteins (including CD48) inhibits IL-18-dependent tyrosine kinase phosphorylation and IFN-γ production, indicating the CD48/GPI glycan complex is required for IL-18 signaling.","method":"Co-immunoprecipitation; phosphatidylinositol-specific phospholipase C treatment; tyrosine phosphorylation assay; IFN-γ production","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP plus enzymatic removal of GPI proteins with functional readout; single lab","pmids":["15760905"],"is_preprint":false},{"year":2006,"finding":"CD48 is an IL-3-upregulated activation receptor on human eosinophils; cross-linking CD48 on eosinophils triggers granule protein release (degranulation), and CD48 is induced by allergen challenge in a murine asthma model, establishing CD48 as a functional activating receptor on eosinophils.","method":"Flow cytometry; IL-3 stimulation; CD48 cross-linking degranulation assay; murine asthma model; anti-IL-3 treatment","journal":"Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 — receptor cross-linking functional assay in primary cells plus in vivo model corroboration","pmids":["16785501"],"is_preprint":false},{"year":2009,"finding":"GPI-anchored CD48 (but not CD59) is recruited to the immobilised TCR/CD3 complex upon T cell activation. CD48 reorganisation is required for IL-2 production by mediating lateral association of the adaptor LAT with the TCR/CD3 complex. CD2 acts hierarchically upstream, associating with TCR/CD3 irrespective of CD48 and recruiting CD48 and Lck; CD48 in turn shuttles LAT to the complex.","method":"Co-immunoprecipitation; siRNA knockdown of CD48; IL-2 production assay; sequential co-IP establishing CD2→CD48→LAT hierarchy","journal":"Journal of Immunology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP with siRNA-mediated loss of function and clear IL-2 functional readout establishing pathway hierarchy","pmids":["19494291"],"is_preprint":false},{"year":2013,"finding":"ORMDL3 overexpression in eosinophils regulates IL-3-induced expression of CD48, and CD48-mediated eosinophil degranulation; ORMDL3 knockdown inhibits CD48 surface expression as well as activation-induced cell shape changes and recruitment to inflammation, placing ORMDL3 upstream of CD48 in eosinophil activation.","method":"ORMDL3 overexpression/knockdown in eosinophils; flow cytometry; degranulation assay; in vivo recruitment assay","journal":"Nature Communications","confidence":"Medium","confidence_rationale":"Tier 2 — gain and loss of function with functional degranulation readout; single lab","pmids":["24056518"],"is_preprint":false},{"year":2014,"finding":"CD48 on human and murine eosinophils directly binds Staphylococcus aureus and its exotoxins (SEB, protein A, peptidoglycan); SA/exotoxins enhance CD48 expression, aggregate at CD48 sites (confocal microscopy), and trigger eosinophil activation, degranulation, and cytokine release in a CD48-dependent manner confirmed in CD48-/- mouse bone marrow eosinophils.","method":"Confocal microscopy (CD48 aggregation at SA binding sites); blocking anti-CD48 antibody; CD48-/- mouse eosinophils; degranulation assay; cytokine ELISA; in vivo peritonitis model","journal":"Clinical and Experimental Allergy","confidence":"High","confidence_rationale":"Tier 2 — genetic KO combined with multiple functional assays and in vivo model","pmids":["25255823"],"is_preprint":false},{"year":2019,"finding":"A cytomegalovirus-encoded soluble CD48 homolog (A43) binds host 2B4 with high affinity and slow dissociation (surface plasmon resonance), abrogates host CD48:2B4 interactions, reduces NK cell-target conjugate formation, prevents immunological synapse establishment, and severely impairs 2B4-mediated NK cytotoxicity and IFN-γ production — establishing CD48:2B4 as required for NK effector function.","method":"Surface plasmon resonance; NK cytotoxicity assay; conjugate formation assay; IFN-γ measurement; viral protein functional characterisation","journal":"PLoS Pathogens","confidence":"High","confidence_rationale":"Tier 1/2 — SPR quantitative binding combined with multiple independent NK functional assays","pmids":["30947296"],"is_preprint":false},{"year":2020,"finding":"CD48 expression in AML is regulated by DNA methylation; a hypomethylating agent increases CD48 expression on AML cells, restoring NK cell killing in vitro, and CD48 high expression reverses AML immune evasion and activates NK cell function in vivo.","method":"DNA methylation analysis; hypomethylating agent treatment; NK co-culture cytotoxicity assay; in vivo AML mouse model","journal":"Clinical Science","confidence":"Medium","confidence_rationale":"Tier 2 — epigenetic writer identified, in vitro and in vivo functional rescue demonstrated; single lab","pmids":["31922199"],"is_preprint":false},{"year":2020,"finding":"CD48 expression in human innate lymphoid cell precursors (ILCPs) modulates ILC differentiation: 2B4:CD48 interaction (between co-expressed 2B4 and CD48 on progenitors) specifically induces ILC2 differentiation in vitro, and CD48-expressing progenitors give rise to tissue-associated ILCs in vivo.","method":"In vitro progenitor differentiation assay; blocking antibodies against 2B4/CD48; in vivo xenograft (progenitor transfer); flow cytometry","journal":"Science Immunology","confidence":"Medium","confidence_rationale":"Tier 2 — receptor blocking plus in vivo transfer experiment; single lab","pmids":["33219153"],"is_preprint":false},{"year":2021,"finding":"GDF15 binds CD48 on T cells as a previously unrecognised receptor; GDF15:CD48 interaction downregulates STUB1 (an E3 ubiquitin ligase that mediates FOXP3 degradation), thereby stabilising FOXP3, promoting iTreg generation and enhancing nTreg suppressive function. Co-immunoprecipitation confirmed GDF15-CD48 physical interaction.","method":"Co-immunoprecipitation; RNA sequencing; mass spectrometry; ChIP; flow cytometry; GDF15 KO mouse model; STUB1/FOXP3 protein stability assays","journal":"Journal for Immunotherapy of Cancer","confidence":"High","confidence_rationale":"Tier 1/2 — multiple orthogonal methods (co-IP, mass spec, ChIP, genetic KO, functional rescue) identifying novel receptor-ligand pair and downstream mechanism","pmids":["34489334"],"is_preprint":false},{"year":2022,"finding":"Genome-wide CRISPR screen identified CD48 as the key determinant of ATLL cell susceptibility to NK cell-mediated cytotoxicity; CD48 knockout conferred resistance to NK killing, reduced IFN-γ induction and degranulation by primary NK cells, and primary ATLL cells showed reduced CD48 expression with disease progression.","method":"Genome-wide CRISPR knockout screen; primary NK cell cytotoxicity assay; IFN-γ and CD107a degranulation assays; flow cytometry of primary ATLL samples","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — unbiased genome-wide CRISPR screen with functional validation using primary NK cells and patient samples","pmids":["35921533"],"is_preprint":false},{"year":2022,"finding":"HO-1 overexpression in AML cells specifically downregulates CD48 expression by directly interacting with Sirt1, increasing its deacetylase activity, leading to H3K27 deacetylation at the CD48 promoter to suppress CD48 transcription; Sirt1 inhibition restores CD48 expression, confirming the HO-1→Sirt1→H3K27 deacetylation→CD48 suppression axis.","method":"Co-immunoprecipitation (HO-1/Sirt1); Western blot; qRT-PCR; flow cytometry; Sirt1 inhibitor rescue; NK co-culture cytotoxicity; in vivo AML mouse model","journal":"Journal of Translational Medicine","confidence":"High","confidence_rationale":"Tier 1/2 — co-IP establishing direct interaction, epigenetic mechanism validated with enzymatic inhibitor rescue, in vivo corroboration","pmids":["36058936"],"is_preprint":false},{"year":2024,"finding":"KDM6A (H3K27me3 demethylase) epigenetically regulates CD48 expression: KDM6A loss increases H3K27me3 on the CD48 promoter, markedly downregulating CD48, which contributes to resistance to daratumumab-mediated ADCC in multiple myeloma. EZH2 inhibitor treatment restores CD48 (and CD38) expression and reverses ADCC resistance.","method":"Genome-wide CRISPR screen; ChIP-seq (H3K27me3 at CD48 promoter); EZH2 inhibitor rescue; NK ADCC assay; flow cytometry","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 1/2 — CRISPR screen, ChIP-seq mechanistic validation, pharmacological rescue with multiple functional readouts","pmids":["38355622"],"is_preprint":false},{"year":2020,"finding":"AML1-ETO fusion oncoprotein increases CD48 expression on AML cells through AML1-ETO/P300-mediated acetylation of CD48, inhibiting NK cell immune evasion; this provides a mechanism for the better clinical outcomes observed in AML1-ETO-positive AML.","method":"Immunoprecipitation; Western blot; flow cytometry; NK co-culture cytotoxicity assay","journal":"Leukemia and Lymphoma","confidence":"Medium","confidence_rationale":"Tier 3 — single-lab co-IP and functional assay identifying acetylation writer; moderate evidence","pmids":["33225787"],"is_preprint":false},{"year":2019,"finding":"TGF-β downregulates CD48 surface expression on leukemia cells (MEG-01 and U937), reducing their susceptibility to NK-92MI killing and conjugate formation; CD48 knockdown phenocopies TGF-β treatment, confirming CD48 as the relevant target for TGF-β-mediated NK evasion of leukemia cells.","method":"TGF-β treatment; CD48 knockdown; NK co-culture cytotoxicity assay; conjugate formation assay; flow cytometry","journal":"Immunobiology","confidence":"Medium","confidence_rationale":"Tier 3 — cytokine treatment with genetic knockdown phenocopy; single lab","pmids":["31421859"],"is_preprint":false},{"year":1994,"finding":"Occupancy of CD2 on mouse B cells by soluble recombinant mouse CD48 (its natural ligand) prevents antigen-induced apoptosis and upregulates Bcl-2 expression; anti-CD48 antibody abrogates allogeneic cell-induced clonal expansion, establishing that CD2-CD48 interaction controls B cell survival decisions.","method":"Soluble recombinant CD48 treatment; anti-CD48 blocking mAb; apoptosis (DNA fragmentation) assay; Bcl-2 Western blot","journal":"European Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 — recombinant ligand plus blocking antibody with apoptosis and Bcl-2 molecular readout; single lab","pmids":["7925579"],"is_preprint":false}],"current_model":"CD48 is a GPI-anchored cell-surface glycoprotein of the CD2/SLAM family that functions as a co-stimulatory adhesion and signaling molecule on hematopoietic cells: it interacts head-to-head with CD2 (via its membrane-distal Ig domain) to enhance TCR signaling by recruiting lipid rafts, LAT, and Lck to the TCR complex; it serves as the high-affinity ligand for 2B4 (CD244) on NK and T cells to regulate NK cytotoxicity, CD8+ T cell proliferation, and ILC differentiation; it acts as a receptor for GDF15 to stabilize FOXP3 in Tregs via STUB1 suppression; its surface expression is epigenetically controlled by KDM6A/EZH2 (H3K27me3), HO-1/Sirt1 (H3K27 deacetylation), and DNA methylation; and it mediates mast cell and eosinophil activation upon encounter with bacterial pathogens including M. tuberculosis and S. aureus."},"narrative":{"teleology":[{"year":1994,"claim":"Before CD48's functional role was clear, demonstrating that soluble CD48 engagement of CD2 on B cells prevented antigen-induced apoptosis and upregulated Bcl-2 established that the CD2–CD48 axis delivers survival signals beyond simple adhesion.","evidence":"Soluble recombinant CD48 treatment of mouse B cells with apoptosis/Bcl-2 readouts and anti-CD48 blockade","pmids":["7925579"],"confidence":"Medium","gaps":["Downstream signaling intermediates between CD2 engagement and Bcl-2 upregulation not identified","Limited to B cells; generalizability to other lineages untested"]},{"year":1995,"claim":"Identifying the CD2-binding site on the GFCC'C'' β-sheet of CD48's membrane-distal Ig domain through complementary charge-swap mutagenesis established the head-to-head topology of the CD2–CD48 complex spanning ~134 Å, defining the structural framework for all subsequent interaction studies.","evidence":"Complementary mutagenesis of rat CD2 and CD48 extracellular domains with structural modeling","pmids":["7697352"],"confidence":"High","gaps":["No high-resolution co-crystal structure at the time","Rat system; human interface details inferred"]},{"year":1996,"claim":"Single-molecule force measurements and SPR quantified the CD2–CD48 bond as weak and rapidly dissociating (~7.8 s⁻¹ off-rate, ~10⁴ M⁻¹ affinity), resolving how this interaction enables dynamic T cell scanning rather than stable adhesion.","evidence":"Flow chamber single-bond kinetics and surface plasmon resonance with purified rat CD2/CD48","pmids":["8986773","9188168"],"confidence":"High","gaps":["Measurements performed with rat proteins; human kinetics not yet determined","How weak affinity translates to functional signaling thresholds in vivo remained unclear"]},{"year":1998,"claim":"Three concurrent advances established CD48's dual receptor partnerships and functional consequences: identification of 2B4 (CD244) as a second counter-receptor for CD48, demonstration that CD48 on APCs co-stimulates antigen-specific T cell activation via CD2, and the discovery that GPI-anchored CD48 enhances TCR signaling through lipid raft-dependent recruitment of TCR-ζ to the actin cytoskeleton.","evidence":"CD48-Ig fusion binding/IP identifying 2B4; CHO transfectant co-stimulation assays with anti-CD2 blockade; lipid raft fractionation and ζ-chain phosphorylation analysis","pmids":["9834056","9862369","9881969"],"confidence":"High","gaps":["Relative contributions of CD2 vs 2B4 engagement to downstream signaling not delineated","Signaling intermediates between CD48 raft association and ζ phosphorylation unknown"]},{"year":1999,"claim":"CD48 knockout mice showed severely impaired CD4⁺ T cell activation to mitogens, anti-CD3, and alloantigens, providing genetic proof that CD48 is required on both T cells and APCs for efficient TCR signaling in vivo.","evidence":"Gene-targeted CD48⁻/⁻ mice with T cell proliferation, MLR, and reciprocal cell-mixing experiments","pmids":["9927686"],"confidence":"High","gaps":["NK cell phenotype in CD48⁻/⁻ mice not characterized in this study","Whether CD48 loss affects thymic selection not addressed"]},{"year":1999,"claim":"Demonstrating that human 2B4 binds CD48 with high affinity and that CD48 engagement triggers NK cytotoxicity and IFN-γ production established the CD48–2B4 axis as a principal activating pathway for human NK cells.","evidence":"Soluble NAIL-Fc binding assay; NK cytotoxicity and IFN-γ measurement with CD48 protein and anti-2B4 mAb ligation","pmids":["10359122","10556801"],"confidence":"High","gaps":["SAP-dependent vs SAP-independent signaling downstream of 2B4 not resolved","Whether 2B4 can also deliver inhibitory signals (as later shown in XLP) not yet addressed"]},{"year":2000,"claim":"Immunogold EM and confocal microscopy showed CD48 co-clusters with IL-2Rα and HLA in cholesterol-dependent lipid raft microdomains (~600–800 nm), and cholesterol depletion dispersed these clusters, establishing the biophysical basis for CD48's role as a raft-resident signaling organizer.","evidence":"Immunogold EM and confocal on T lymphoma cells; cholesterol depletion with filipin and methyl-β-cyclodextrin","pmids":["10823948"],"confidence":"High","gaps":["Dynamic behavior of CD48 in rafts during active signaling not captured","Whether CD48 itself nucleates raft assembly or is passively recruited unknown"]},{"year":2003,"claim":"Discovery that CD48 on mast cells directly binds Mycobacterium tuberculosis and mediates histamine release revealed an unexpected innate immune function for CD48 as a bacterial pattern recognition receptor, extending its role beyond lymphocyte co-stimulation.","evidence":"Confocal microscopy of CD48 aggregation at mycobacterial binding sites; anti-CD48 blockade of histamine release","pmids":["12759438"],"confidence":"Medium","gaps":["Specific mycobacterial ligand recognized by CD48 not identified","Single lab; no independent confirmation at the time"]},{"year":2005,"claim":"Multiple studies showed that homotypic 2B4–CD48 interactions among NK cells are essential for IL-2-driven NK expansion and that DC-subset-specific CD48 expression tunes whether 2B4 delivers activating or inhibitory signals, revealing context-dependent functional outcomes of the same receptor–ligand pair.","evidence":"2B4-deficient NK cells with cytotoxicity/calcium/IFN-γ readouts and GFP-2B4 live imaging; NK:DC co-culture with XLP patient NK cells","pmids":["15905190","16148114"],"confidence":"High","gaps":["Molecular switch between activating and inhibitory 2B4 signaling not fully resolved","Role of SAP/EAT-2 adaptor balance in determining outcome not mechanistically dissected"]},{"year":2005,"claim":"Co-immunoprecipitation of CD48 with IL-18Rα and the finding that GPI-anchor removal abolished IL-18-dependent tyrosine phosphorylation and IFN-γ production identified an unexpected role for CD48 in IL-18 receptor signaling, potentially through its GPI glycan.","evidence":"Co-IP from IL-18-stimulated KG-1 cells; phospholipase C treatment with functional readout","pmids":["15760905"],"confidence":"Medium","gaps":["PLC treatment removes all GPI-anchored proteins, not just CD48","No reciprocal validation or CD48-specific knockdown to confirm specificity"]},{"year":2009,"claim":"Establishing the CD2→CD48→LAT signaling hierarchy at the TCR complex resolved how CD48 functions mechanistically as a molecular shuttle: CD2 first associates with TCR/CD3 and recruits CD48 and Lck, then CD48 brings LAT to the complex, which is required for IL-2 production.","evidence":"Sequential co-IP of TCR/CD3 complex components; CD48 siRNA knockdown with IL-2 functional readout in T cells","pmids":["19494291"],"confidence":"High","gaps":["How GPI-anchored CD48 (lacking cytoplasmic tail) physically associates with LAT not mechanistically explained","Whether this hierarchy operates identically in CD8⁺ T cells not tested"]},{"year":2014,"claim":"Demonstrating that CD48 on eosinophils directly binds Staphylococcus aureus and its exotoxins, triggering degranulation confirmed in CD48⁻/⁻ mice, consolidated CD48's role as a bacterial sensor on innate immune cells beyond mast cells.","evidence":"Confocal imaging, anti-CD48 blockade, CD48⁻/⁻ mouse eosinophils, in vivo peritonitis model","pmids":["25255823"],"confidence":"High","gaps":["Molecular identity of the bacterial surface moiety recognized by CD48 still unknown","Signaling pathway downstream of CD48 in eosinophils not characterized"]},{"year":2019,"claim":"A CMV-encoded soluble CD48 homolog (A43) that binds host 2B4 with high affinity and blocks NK immunological synapse formation provided evolutionary evidence that the CD48–2B4 axis is critical enough for antiviral immunity that viruses evolved a decoy to subvert it.","evidence":"SPR kinetics of viral A43–2B4 binding; NK conjugation, cytotoxicity, and IFN-γ assays","pmids":["30947296"],"confidence":"High","gaps":["In vivo significance of A43 in CMV immune evasion not demonstrated","Whether other viral CD48 mimics exist not surveyed"]},{"year":2020,"claim":"Multiple groups showed that DNA methylation and the AML1-ETO/P300 axis regulate CD48 expression in leukemia, with hypomethylating agents or AML1-ETO restoring CD48 and NK killing, linking CD48 epigenetic silencing to tumor immune evasion.","evidence":"DNA methylation analysis with HMA treatment; AML1-ETO/P300 co-IP; NK co-culture cytotoxicity in vitro and in vivo AML models","pmids":["31922199","33225787"],"confidence":"Medium","gaps":["Whether DNA methylation and histone modifications cooperate at the CD48 locus not addressed","Patient-level correlation between CD48 methylation and clinical outcome limited"]},{"year":2020,"claim":"Discovery that 2B4–CD48 interactions on innate lymphoid cell precursors direct ILC2 differentiation extended CD48's functional repertoire from mature effector cell co-stimulation to lineage specification of innate lymphoid cells.","evidence":"In vitro ILCP differentiation with 2B4/CD48 blocking antibodies; in vivo xenograft progenitor transfer","pmids":["33219153"],"confidence":"Medium","gaps":["Downstream transcriptional program linking 2B4/CD48 to ILC2 commitment not identified","Single lab; independent replication lacking"]},{"year":2021,"claim":"Identifying GDF15 as a novel ligand for CD48 that stabilizes FOXP3 by suppressing STUB1-mediated ubiquitination revealed a previously unknown receptor function for CD48 in regulatory T cell biology, distinct from its CD2/2B4-binding roles.","evidence":"Co-IP, mass spectrometry, ChIP, RNA-seq, GDF15 KO mice, STUB1/FOXP3 protein stability assays","pmids":["34489334"],"confidence":"High","gaps":["Binding interface between GDF15 and CD48 not structurally characterized","Whether GDF15–CD48 competes with CD2 or 2B4 binding not determined","Downstream signaling from GPI-anchored CD48 to STUB1 suppression unresolved"]},{"year":2022,"claim":"Convergent CRISPR screens and epigenetic dissection established that KDM6A demethylase maintains CD48 expression via H3K27me3 removal at the CD48 promoter, while HO-1/Sirt1-mediated H3K27 deacetylation suppresses it, defining a dual epigenetic rheostat controlling CD48-dependent immune recognition of tumor cells.","evidence":"Genome-wide CRISPR screens in ATLL and myeloma; ChIP-seq for H3K27me3; HO-1/Sirt1 co-IP; EZH2 and Sirt1 inhibitor rescue; NK ADCC and cytotoxicity assays","pmids":["35921533","36058936","38355622"],"confidence":"High","gaps":["Interplay between KDM6A/EZH2 axis and HO-1/Sirt1 axis at the same locus not examined","Whether these epigenetic mechanisms are tumor-type-specific or general remains untested"]},{"year":null,"claim":"Key unresolved questions include: the structural basis of the GDF15–CD48 interaction, how GPI-anchored CD48 (lacking a cytoplasmic domain) transduces intracellular signals to LAT or STUB1, the identity of bacterial surface moieties recognized by CD48, and whether the multiple epigenetic control mechanisms converge on a unified chromatin state at the CD48 locus.","evidence":"","pmids":[],"confidence":"Low","gaps":["No co-crystal structure of CD48 with any of its ligands","Signaling mechanism from GPI-anchor to intracellular effectors undefined","Bacterial ligands for CD48 unidentified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,4,5,7,16]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[3,6,22]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[3,6,12,18]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,4,8,16]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[1,2]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[4,6,7,12,18,19,23]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,16,22]}],"complexes":[],"partners":["CD2","CD244","LAT","LCK","GDF15","IL18R1","SIRT1","HMOX1"],"other_free_text":[]},"mechanistic_narrative":"CD48 is a GPI-anchored cell-surface glycoprotein of the CD2/SLAM family that functions as a multivalent co-stimulatory and adhesion molecule on hematopoietic cells, integrating signals that regulate T cell activation, NK cell cytotoxicity, innate lymphoid cell differentiation, and mast cell/eosinophil responses to bacterial pathogens. CD48 engages CD2 via a head-to-head interaction of its membrane-distal immunoglobulin domain with weak, rapidly dissociating affinity (~10⁴ M⁻¹), and this interaction enhances TCR signaling by recruiting CD48 into lipid raft microdomains where it shuttles the adaptor LAT and Lck to the TCR/CD3 complex in a CD2→CD48→LAT hierarchy [PMID:7697352, PMID:9881969, PMID:19494291]. CD48 also serves as the primary ligand for 2B4 (CD244), through which it triggers NK cell cytotoxicity, IFN-γ production, and CD8⁺ T cell proliferation, and homotypic 2B4–CD48 interactions on innate lymphoid cell precursors direct ILC2 differentiation [PMID:9834056, PMID:10359122, PMID:15905190, PMID:33219153]. CD48 surface expression is epigenetically controlled by H3K27 methylation/demethylation (KDM6A/EZH2) and H3K27 deacetylation (HO-1/Sirt1), and by DNA methylation, mechanisms exploited by tumor cells for NK immune evasion [PMID:38355622, PMID:36058936, PMID:31922199]."},"prefetch_data":{"uniprot":{"accession":"P09326","full_name":"CD48 antigen","aliases":["B-lymphocyte activation marker BLAST-1","BCM1 surface antigen","Leukocyte antigen MEM-102","SLAM family member 2","SLAMF2","Signaling lymphocytic activation molecule 2","TCT.1"],"length_aa":243,"mass_kda":27.7,"function":"Glycosylphosphatidylinositol (GPI)-anchored cell surface glycoprotein that interacts via its N-terminal immunoglobulin domain with cell surface receptors including CD244/2B4 or CD2 to regulate immune cell function and activation (PubMed:12007789, PubMed:19494291, PubMed:27249817, PubMed:9841922). Participates in T-cell signaling transduction by associating with CD2 and efficiently bringing the Src family protein kinase LCK and LAT to the TCR/CD3 complex (PubMed:19494291). In turn, promotes LCK phosphorylation and subsequent activation (PubMed:12007789). Induces the phosphorylation of the cytoplasmic immunoreceptortyrosine switch motifs (ITSMs) of CD244 initiating a series of signaling events that leads to the generation of the immunological synapse and the directed release of cytolytic granules containing perforin and granzymes by T-lymphocytes and NK-cells (PubMed:27249817)","subcellular_location":"Cell membrane; Membrane raft; Secreted","url":"https://www.uniprot.org/uniprotkb/P09326/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CD48","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CD48","total_profiled":1310},"omim":[{"mim_id":"606625","title":"SLAM FAMILY, MEMBER 7; SLAMF7","url":"https://www.omim.org/entry/606625"},{"mim_id":"606620","title":"SLAM FAMILY, MEMBER 8; SLAMF8","url":"https://www.omim.org/entry/606620"},{"mim_id":"606446","title":"SLAM FAMILY, MEMBER 6; SLAMF6","url":"https://www.omim.org/entry/606446"},{"mim_id":"605554","title":"CD244 ANTIGEN; CD244","url":"https://www.omim.org/entry/605554"},{"mim_id":"604513","title":"CD84 ANTIGEN; CD84","url":"https://www.omim.org/entry/604513"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Nucleoli fibrillar center","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":140.1},{"tissue":"lymphoid tissue","ntpm":265.6}],"url":"https://www.proteinatlas.org/search/CD48"},"hgnc":{"alias_symbol":["BLAST","mCD48","hCD48","SLAMF2"],"prev_symbol":["BCM1"]},"alphafold":{"accession":"P09326","domains":[{"cath_id":"2.60.40.10","chopping":"31-129","consensus_level":"high","plddt":95.1989,"start":31,"end":129},{"cath_id":"2.60.40.10","chopping":"136-218","consensus_level":"high","plddt":90.0041,"start":136,"end":218}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P09326","model_url":"https://alphafold.ebi.ac.uk/files/AF-P09326-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P09326-F1-predicted_aligned_error_v6.png","plddt_mean":82.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CD48","jax_strain_url":"https://www.jax.org/strain/search?query=CD48"},"sequence":{"accession":"P09326","fasta_url":"https://rest.uniprot.org/uniprotkb/P09326.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P09326/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P09326"}},"corpus_meta":[{"pmid":"9254694","id":"PMC_9254694","title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.","date":"1997","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9254694","citation_count":53619,"is_preprint":false},{"pmid":"20003500","id":"PMC_20003500","title":"BLAST+: architecture and applications.","date":"2009","source":"BMC bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/20003500","citation_count":14886,"is_preprint":false},{"pmid":"11932250","id":"PMC_11932250","title":"BLAT--the BLAST-like alignment tool.","date":"2002","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11932250","citation_count":6485,"is_preprint":false},{"pmid":"22593173","id":"PMC_22593173","title":"Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model.","date":"2012","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22593173","citation_count":751,"is_preprint":false},{"pmid":"22510480","id":"PMC_22510480","title":"Domain enhanced lookup time accelerated BLAST.","date":"2012","source":"Biology direct","url":"https://pubmed.ncbi.nlm.nih.gov/22510480","citation_count":623,"is_preprint":false},{"pmid":"14982876","id":"PMC_14982876","title":"The biology of CML blast crisis.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/14982876","citation_count":422,"is_preprint":false},{"pmid":"6172535","id":"PMC_6172535","title":"A nuclear antigen associated with cell proliferation and blast transformation.","date":"1981","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/6172535","citation_count":350,"is_preprint":false},{"pmid":"3477958","id":"PMC_3477958","title":"Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.","date":"1987","source":"The American journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/3477958","citation_count":263,"is_preprint":false},{"pmid":"9881969","id":"PMC_9881969","title":"Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: a role for lipid rafts in T cell activation.","date":"1998","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9881969","citation_count":210,"is_preprint":false},{"pmid":"10359122","id":"PMC_10359122","title":"Activating interactions in human NK cell recognition: the role of 2B4-CD48.","date":"1999","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10359122","citation_count":208,"is_preprint":false},{"pmid":"26794910","id":"PMC_26794910","title":"Roles of CD48 in regulating immunity and tolerance.","date":"2016","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/26794910","citation_count":171,"is_preprint":false},{"pmid":"34489334","id":"PMC_34489334","title":"GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma.","date":"2021","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34489334","citation_count":134,"is_preprint":false},{"pmid":"20627803","id":"PMC_20627803","title":"Recent advances in rice blast effector research.","date":"2010","source":"Current opinion in plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/20627803","citation_count":132,"is_preprint":false},{"pmid":"9834056","id":"PMC_9834056","title":"Identification of the 2B4 molecule as a counter-receptor for CD48.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9834056","citation_count":130,"is_preprint":false},{"pmid":"10823948","id":"PMC_10823948","title":"Cholesterol-dependent clustering of IL-2Ralpha and its colocalization with HLA and CD48 on T lymphoma cells suggest their functional association with lipid rafts.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10823948","citation_count":126,"is_preprint":false},{"pmid":"32367535","id":"PMC_32367535","title":"Ferroptosis contributes to developmental cell death in rice blast.","date":"2020","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/32367535","citation_count":123,"is_preprint":false},{"pmid":"34111285","id":"PMC_34111285","title":"Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/34111285","citation_count":120,"is_preprint":false},{"pmid":"7697352","id":"PMC_7697352","title":"Topology of the CD2-CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells.","date":"1995","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/7697352","citation_count":119,"is_preprint":false},{"pmid":"18480120","id":"PMC_18480120","title":"GeneCAT--novel webtools that combine BLAST and co-expression analyses.","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18480120","citation_count":116,"is_preprint":false},{"pmid":"17905473","id":"PMC_17905473","title":"Susceptibility of rice to the blast fungus, Magnaporthe grisea.","date":"2007","source":"Journal of plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17905473","citation_count":105,"is_preprint":false},{"pmid":"30975460","id":"PMC_30975460","title":"RRM Transcription Factors Interact with NLRs and Regulate Broad-Spectrum Blast Resistance in Rice.","date":"2019","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30975460","citation_count":104,"is_preprint":false},{"pmid":"24056518","id":"PMC_24056518","title":"ORMDL3 promotes eosinophil trafficking and activation via regulation of integrins and CD48.","date":"2013","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24056518","citation_count":98,"is_preprint":false},{"pmid":"27641772","id":"PMC_27641772","title":"Immunity to Rice Blast Disease by Suppression of Effector-Triggered Necrosis.","date":"2016","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/27641772","citation_count":98,"is_preprint":false},{"pmid":"7903681","id":"PMC_7903681","title":"Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival.","date":"1994","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/7903681","citation_count":95,"is_preprint":false},{"pmid":"21861635","id":"PMC_21861635","title":"Factors affecting blast traumatic brain injury.","date":"2011","source":"Journal of neurotrauma","url":"https://pubmed.ncbi.nlm.nih.gov/21861635","citation_count":87,"is_preprint":false},{"pmid":"31513573","id":"PMC_31513573","title":"Effector gene reshuffling involves dispensable mini-chromosomes in the wheat blast fungus.","date":"2019","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31513573","citation_count":85,"is_preprint":false},{"pmid":"24412978","id":"PMC_24412978","title":"EC-BLAST: a tool to automatically search and compare enzyme reactions.","date":"2014","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/24412978","citation_count":85,"is_preprint":false},{"pmid":"21653517","id":"PMC_21653517","title":"genBlastG: using BLAST searches to build homologous gene models.","date":"2011","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21653517","citation_count":83,"is_preprint":false},{"pmid":"10556801","id":"PMC_10556801","title":"Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48.","date":"1999","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10556801","citation_count":81,"is_preprint":false},{"pmid":"36943033","id":"PMC_36943033","title":"UniProt Tools: BLAST, Align, Peptide Search, and ID Mapping.","date":"2023","source":"Current protocols","url":"https://pubmed.ncbi.nlm.nih.gov/36943033","citation_count":80,"is_preprint":false},{"pmid":"12759438","id":"PMC_12759438","title":"Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12759438","citation_count":80,"is_preprint":false},{"pmid":"15905190","id":"PMC_15905190","title":"Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15905190","citation_count":75,"is_preprint":false},{"pmid":"9927686","id":"PMC_9927686","title":"CD48-deficient mice have a pronounced defect in CD4(+) T cell activation.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9927686","citation_count":74,"is_preprint":false},{"pmid":"27574197","id":"PMC_27574197","title":"Sequence Alignment and Homology Search with BLAST and ClustalW.","date":"2016","source":"Cold Spring Harbor protocols","url":"https://pubmed.ncbi.nlm.nih.gov/27574197","citation_count":71,"is_preprint":false},{"pmid":"18024655","id":"PMC_18024655","title":"The Biology of CML blast crisis.","date":"2007","source":"Hematology. American Society of Hematology. Education Program","url":"https://pubmed.ncbi.nlm.nih.gov/18024655","citation_count":70,"is_preprint":false},{"pmid":"21088027","id":"PMC_21088027","title":"GPU-BLAST: using graphics processors to accelerate protein sequence alignment.","date":"2010","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21088027","citation_count":68,"is_preprint":false},{"pmid":"8986773","id":"PMC_8986773","title":"Determination of the lifetime and force dependence of interactions of single bonds between surface-attached CD2 and CD48 adhesion molecules.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8986773","citation_count":68,"is_preprint":false},{"pmid":"19422293","id":"PMC_19422293","title":"Biomarkers of blast-induced neurotrauma: profiling molecular and cellular mechanisms of blast brain injury.","date":"2009","source":"Journal of neurotrauma","url":"https://pubmed.ncbi.nlm.nih.gov/19422293","citation_count":66,"is_preprint":false},{"pmid":"20833258","id":"PMC_20833258","title":"CD48: A co-stimulatory receptor of immunity.","date":"2010","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20833258","citation_count":62,"is_preprint":false},{"pmid":"25403621","id":"PMC_25403621","title":"Genome-wide association study of blast resistance in indica rice.","date":"2014","source":"BMC plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/25403621","citation_count":60,"is_preprint":false},{"pmid":"27839570","id":"PMC_27839570","title":"Management of CML-blast crisis.","date":"2016","source":"Best practice & research. Clinical haematology","url":"https://pubmed.ncbi.nlm.nih.gov/27839570","citation_count":58,"is_preprint":false},{"pmid":"11739483","id":"PMC_11739483","title":"Cutting edge: Regulation of CD8(+) T cell proliferation by 2B4/CD48 interactions.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11739483","citation_count":57,"is_preprint":false},{"pmid":"16785501","id":"PMC_16785501","title":"CD48 is an allergen and IL-3-induced activation molecule on eosinophils.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16785501","citation_count":51,"is_preprint":false},{"pmid":"25814082","id":"PMC_25814082","title":"Management of chronic myeloid leukemia in blast crisis.","date":"2015","source":"Annals of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/25814082","citation_count":51,"is_preprint":false},{"pmid":"9418191","id":"PMC_9418191","title":"Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis.","date":"1997","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9418191","citation_count":47,"is_preprint":false},{"pmid":"29735658","id":"PMC_29735658","title":"Osmotic stabilization prevents cochlear synaptopathy after blast trauma.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29735658","citation_count":42,"is_preprint":false},{"pmid":"36952381","id":"PMC_36952381","title":"The OsBDR1-MPK3 module negatively regulates blast resistance by suppressing the jasmonate signaling and terpenoid biosynthesis pathway.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/36952381","citation_count":41,"is_preprint":false},{"pmid":"19494291","id":"PMC_19494291","title":"Sequential cooperation of CD2 and CD48 in the buildup of the early TCR signalosome.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19494291","citation_count":40,"is_preprint":false},{"pmid":"24726403","id":"PMC_24726403","title":"Hippocampal vulnerability and subacute response following varied blast magnitudes.","date":"2014","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/24726403","citation_count":40,"is_preprint":false},{"pmid":"3081632","id":"PMC_3081632","title":"Biochemical analysis suggests distinct functional roles for the BLAST-1 and BLAST-2 antigens.","date":"1986","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/3081632","citation_count":40,"is_preprint":false},{"pmid":"17993672","id":"PMC_17993672","title":"BLAST QuickStart: example-driven web-based BLAST tutorial.","date":"2007","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/17993672","citation_count":37,"is_preprint":false},{"pmid":"25472427","id":"PMC_25472427","title":"Exacerbation of blast-induced ocular trauma by an immune response.","date":"2014","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/25472427","citation_count":37,"is_preprint":false},{"pmid":"8101540","id":"PMC_8101540","title":"CD4+8- and CD4-8+ mature thymocytes require different post-selection processing for final development.","date":"1993","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8101540","citation_count":36,"is_preprint":false},{"pmid":"25255823","id":"PMC_25255823","title":"The CD48 receptor mediates Staphylococcus aureus human and murine eosinophil activation.","date":"2014","source":"Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25255823","citation_count":35,"is_preprint":false},{"pmid":"26467468","id":"PMC_26467468","title":"OsGF14b Positively Regulates Panicle Blast Resistance but Negatively Regulates Leaf Blast Resistance in Rice.","date":"2015","source":"Molecular plant-microbe interactions : MPMI","url":"https://pubmed.ncbi.nlm.nih.gov/26467468","citation_count":35,"is_preprint":false},{"pmid":"16304379","id":"PMC_16304379","title":"Pathobiology of lymphoid and myeloid blast crisis and management issues.","date":"2005","source":"Hematology. American Society of Hematology. Education Program","url":"https://pubmed.ncbi.nlm.nih.gov/16304379","citation_count":34,"is_preprint":false},{"pmid":"16081768","id":"PMC_16081768","title":"2B4/CD48-mediated regulation of lymphocyte activation and function.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16081768","citation_count":34,"is_preprint":false},{"pmid":"34570416","id":"PMC_34570416","title":"Tangeretin inhibits fungal ferroptosis to suppress rice blast.","date":"2021","source":"Journal of integrative plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/34570416","citation_count":34,"is_preprint":false},{"pmid":"8412328","id":"PMC_8412328","title":"Expression of the EVI1 gene in chronic myelogenous leukemia in blast crisis.","date":"1993","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/8412328","citation_count":34,"is_preprint":false},{"pmid":"25820172","id":"PMC_25820172","title":"Confirmation of Pig-a mutation in flow cytometry-identified CD48-deficient T-lymphocytes from F344 rats.","date":"2015","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/25820172","citation_count":32,"is_preprint":false},{"pmid":"24224042","id":"PMC_24224042","title":"Effects of antioxidant treatment on blast-induced brain injury.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24224042","citation_count":32,"is_preprint":false},{"pmid":"35095749","id":"PMC_35095749","title":"Perspectives on Primary Blast Injury of the Brain: Translational Insights Into Non-inertial Low-Intensity Blast Injury.","date":"2022","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35095749","citation_count":28,"is_preprint":false},{"pmid":"35921533","id":"PMC_35921533","title":"Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/35921533","citation_count":27,"is_preprint":false},{"pmid":"38355622","id":"PMC_38355622","title":"Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38355622","citation_count":26,"is_preprint":false},{"pmid":"27859399","id":"PMC_27859399","title":"CD48 on blood leukocytes and in serum of asthma patients varies with severity.","date":"2016","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/27859399","citation_count":25,"is_preprint":false},{"pmid":"31922199","id":"PMC_31922199","title":"Acute myeloid leukemia immune escape by epigenetic CD48 silencing.","date":"2020","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/31922199","citation_count":25,"is_preprint":false},{"pmid":"34236673","id":"PMC_34236673","title":"The Impact of Blast Disease: Past, Present, and Future.","date":"2021","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/34236673","citation_count":25,"is_preprint":false},{"pmid":"26232681","id":"PMC_26232681","title":"Blast induced neurotrauma causes overpressure dependent changes to the DNA methylation equilibrium.","date":"2015","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/26232681","citation_count":25,"is_preprint":false},{"pmid":"16148114","id":"PMC_16148114","title":"Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16148114","citation_count":25,"is_preprint":false},{"pmid":"26033714","id":"PMC_26033714","title":"CD48-deficient T-lymphocytes from DMBA-treated rats have de novo mutations in the endogenous Pig-a gene.","date":"2015","source":"Environmental and molecular mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/26033714","citation_count":25,"is_preprint":false},{"pmid":"31363034","id":"PMC_31363034","title":"Cellular Dynamics and Genomic Identity of Centromeres in Cereal Blast Fungus.","date":"2019","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/31363034","citation_count":24,"is_preprint":false},{"pmid":"35181171","id":"PMC_35181171","title":"Review of blast noise and the auditory system.","date":"2022","source":"Hearing research","url":"https://pubmed.ncbi.nlm.nih.gov/35181171","citation_count":23,"is_preprint":false},{"pmid":"25597910","id":"PMC_25597910","title":"Low-cost blast wave generator for studies of hearing loss and brain injury: blast wave effects in closed spaces.","date":"2015","source":"Journal of neuroscience methods","url":"https://pubmed.ncbi.nlm.nih.gov/25597910","citation_count":23,"is_preprint":false},{"pmid":"21561736","id":"PMC_21561736","title":"The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis.","date":"2011","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/21561736","citation_count":22,"is_preprint":false},{"pmid":"24505299","id":"PMC_24505299","title":"HTLV-1 specific CD8+ T cell function augmented by blockade of 2B4/CD48 interaction in HTLV-1 infection.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24505299","citation_count":22,"is_preprint":false},{"pmid":"9188168","id":"PMC_9188168","title":"Characterisation of the low affinity interaction between rat cell adhesion molecules CD2 and CD48 by analytical ultracentrifugation.","date":"1997","source":"European biophysics journal : EBJ","url":"https://pubmed.ncbi.nlm.nih.gov/9188168","citation_count":22,"is_preprint":false},{"pmid":"27551260","id":"PMC_27551260","title":"Astrocyte Reactivity Following Blast Exposure Involves Aberrant Histone Acetylation.","date":"2016","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27551260","citation_count":22,"is_preprint":false},{"pmid":"7925579","id":"PMC_7925579","title":"CD2-CD48 interaction prevents apoptosis in murine B lymphocytes by up-regulating bcl-2 expression.","date":"1994","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7925579","citation_count":22,"is_preprint":false},{"pmid":"29867715","id":"PMC_29867715","title":"Vestibular Injury After Low-Intensity Blast Exposure.","date":"2018","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29867715","citation_count":21,"is_preprint":false},{"pmid":"1655899","id":"PMC_1655899","title":"Further evidence for a gamma/delta T cell receptor-mediated TCT.1/CD48 recognition.","date":"1991","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1655899","citation_count":21,"is_preprint":false},{"pmid":"31598627","id":"PMC_31598627","title":"Blast Preconditioning Protects Retinal Ganglion Cells and Reveals Targets for Prevention of Neurodegeneration Following Blast-Mediated Traumatic Brian Injury.","date":"2019","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/31598627","citation_count":21,"is_preprint":false},{"pmid":"12356317","id":"PMC_12356317","title":"Direct measurements of heterotypic adhesion between the cell surface proteins CD2 and CD48.","date":"2002","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12356317","citation_count":20,"is_preprint":false},{"pmid":"9862369","id":"PMC_9862369","title":"Enhanced murine CD4+ T cell responses induced by the CD2 ligand CD48.","date":"1998","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9862369","citation_count":20,"is_preprint":false},{"pmid":"32898222","id":"PMC_32898222","title":"SMI-BLAST: a novel supervised search framework based on PSI-BLAST for protein remote homology detection.","date":"2021","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/32898222","citation_count":19,"is_preprint":false},{"pmid":"33893374","id":"PMC_33893374","title":"NK1 antagonists attenuate tau phosphorylation after blast and repeated concussive injury.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33893374","citation_count":19,"is_preprint":false},{"pmid":"23349097","id":"PMC_23349097","title":"Toward a \"structural BLAST\": using structural relationships to infer function.","date":"2013","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/23349097","citation_count":19,"is_preprint":false},{"pmid":"9834253","id":"PMC_9834253","title":"A critical role for CD48 antigen in regulating alloengraftment and lymphohematopoietic recovery after bone marrow transplantation.","date":"1998","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9834253","citation_count":19,"is_preprint":false},{"pmid":"33219153","id":"PMC_33219153","title":"Human innate lymphoid cell precursors express CD48 that modulates ILC differentiation through 2B4 signaling.","date":"2020","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33219153","citation_count":18,"is_preprint":false},{"pmid":"28626499","id":"PMC_28626499","title":"The Effects of Blast Exposure on Protein Deimination in the Brain.","date":"2017","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/28626499","citation_count":18,"is_preprint":false},{"pmid":"30947296","id":"PMC_30947296","title":"Subversion of natural killer cell responses by a cytomegalovirus-encoded soluble CD48 decoy receptor.","date":"2019","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/30947296","citation_count":17,"is_preprint":false},{"pmid":"38081865","id":"PMC_38081865","title":"Is Protein BLAST a thing of the past?","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38081865","citation_count":17,"is_preprint":false},{"pmid":"16109603","id":"PMC_16109603","title":"Clinical implications of blast immunophenotypes in myelodysplastic syndromes.","date":"2005","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/16109603","citation_count":17,"is_preprint":false},{"pmid":"29565710","id":"PMC_29565710","title":"Deletion of MBD2 inhibits proliferation of chronic myeloid leukaemia blast phase cells.","date":"2018","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29565710","citation_count":17,"is_preprint":false},{"pmid":"31421859","id":"PMC_31421859","title":"TGF-β regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression.","date":"2019","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/31421859","citation_count":16,"is_preprint":false},{"pmid":"38653755","id":"PMC_38653755","title":"Phytoalexin sakuranetin attenuates endocytosis and enhances resistance to rice blast.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38653755","citation_count":16,"is_preprint":false},{"pmid":"7684691","id":"PMC_7684691","title":"Identification of the T cell surface signal-transducing glycoprotein sgp-60 as CD48, a counter-receptor for mouse CD2.","date":"1993","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7684691","citation_count":16,"is_preprint":false},{"pmid":"15760905","id":"PMC_15760905","title":"Functional role played by the glycosylphosphatidylinositol anchor glycan of CD48 in interleukin-18-induced interferon-gamma production.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15760905","citation_count":16,"is_preprint":false},{"pmid":"28424745","id":"PMC_28424745","title":"Distinguishing the Unique Neuropathological Profile of Blast Polytrauma.","date":"2017","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/28424745","citation_count":16,"is_preprint":false},{"pmid":"36058936","id":"PMC_36058936","title":"Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48.","date":"2022","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36058936","citation_count":16,"is_preprint":false},{"pmid":"33225787","id":"PMC_33225787","title":"AML1-ETO inhibits acute myeloid leukemia immune escape by CD48.","date":"2020","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/33225787","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43778,"output_tokens":6927,"usd":0.11762},"stage2":{"model":"claude-opus-4-6","input_tokens":10703,"output_tokens":4462,"usd":0.247597},"total_usd":0.365217,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"The CD2-binding site on rat CD48 lies on the equivalent GFCC'C\\\" beta-sheet of its membrane-distal immunoglobulin domain. Complementary mutations showed that two charged residues in CD48's ligand-binding site interact directly with two oppositely charged residues in CD2's ligand-binding site, establishing a head-to-head topology for the CD2-CD48 complex that spans approximately 134 Å.\",\n      \"method\": \"Complementary mutagenesis of CD2 and CD48 extracellular domains; structural modeling\",\n      \"journal\": \"Current Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct mutagenesis of binding interface with reciprocal charge-swap validation; structural modelling corroborated by crystal lattice data\",\n      \"pmids\": [\"7697352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Single-molecule force measurements between surface-attached rat CD2 and CD48 showed that arrests were generated by single molecular bonds with an initial bond dissociation rate of ~7.8 s⁻¹, consistent with surface plasmon resonance affinity constants of ~10⁴ M⁻¹ and a weak, rapidly dissociating interaction.\",\n      \"method\": \"Flow chamber single-bond kinetics; surface plasmon resonance\",\n      \"journal\": \"Proceedings of the National Academy of Sciences USA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biophysical measurement at single-molecule level, corroborated by independent SPR\",\n      \"pmids\": [\"8986773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Analytical ultracentrifugation (sedimentation equilibrium and velocity) of soluble recombinant rat CD2 and CD48 extracellular domains in free solution yielded dissociation constants of 20–110 µM, confirming the weak affinity of the CD2-CD48 interaction without artefacts from surface immobilisation.\",\n      \"method\": \"Analytical ultracentrifugation (sedimentation equilibrium and velocity)\",\n      \"journal\": \"European Biophysics Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — three independent ultracentrifugation methods in free solution, corroborating SPR data\",\n      \"pmids\": [\"9188168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"2B4 was identified as a novel counter-receptor (ligand) for murine CD48 by immunofluorescence and immunoprecipitation experiments using a chimeric CD48-IgG1 fusion protein.\",\n      \"method\": \"CD48-IgG1 fusion protein binding assay; immunofluorescence; immunoprecipitation\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — fusion protein pulldown combined with immunoprecipitation; foundational receptor-ligand identification paper\",\n      \"pmids\": [\"9834056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Engagement of GPI-linked CD48 on T cells by CD2 expressed on APCs enhances TCR-mediated signaling by qualitatively and quantitatively increasing lipid raft-dependent association of the TCR zeta chain with the actin cytoskeleton and zeta tyrosine phosphorylation, implicating lipid rafts as integration platforms for receptor signals and cytoskeletal reorganization.\",\n      \"method\": \"T cell:APC co-stimulation assay; lipid raft fractionation; actin cytoskeleton co-sedimentation; zeta chain phosphorylation analysis\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical methods in one study with clear functional readout\",\n      \"pmids\": [\"9881969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CD48 expressed on antigen-presenting cells (CHO transfectants) enhances murine CD4+ T cell proliferation and IL-2 production in an antigen-specific manner, and this effect is mediated through CD2:CD48 interaction as shown by anti-CD2 mAb blockade; CD48 also increases T cell–APC conjugate formation.\",\n      \"method\": \"CHO transfectant co-stimulation assay; T cell proliferation; IL-2 ELISA; conjugate assay; blocking mAb\",\n      \"journal\": \"European Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean transfectant system with multiple functional readouts, single lab\",\n      \"pmids\": [\"9862369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Human 2B4 (NAIL/CD244) binds CD48 with high affinity as determined by soluble NAIL-Fc fusion protein; engagement of CD48 by recombinant CD48 protein increases NK cell cytotoxicity and induces IFN-γ production, and 2B4 ligation on human NK cells by CD48 or specific mAb triggers NK-mediated cytotoxicity.\",\n      \"method\": \"Soluble fusion protein binding assay; NK cytotoxicity assay; IFN-γ measurement; mAb ligation\",\n      \"journal\": \"European Journal of Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — molecular binding assay plus multiple functional NK cell readouts, independently consistent with other 2B4/CD48 papers\",\n      \"pmids\": [\"10359122\", \"10556801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CD48-deficient mice generated by gene targeting show severely impaired CD4+ T cell activation (reduced proliferative responses to mitogens, anti-CD3 mAb, and alloantigen), demonstrating that CD48 is important on both T cells and antigen-presenting cells for T cell receptor signaling.\",\n      \"method\": \"Gene targeting (knockout mice); T cell proliferation assay; mixed lymphocyte reaction; mitogen stimulation; phorbol ester co-stimulation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences USA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple activation readouts and reciprocal cell-mixing experiments\",\n      \"pmids\": [\"9927686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CD48 co-localises and co-clusters with IL-2Rα and HLA molecules in cholesterol-rich lipid raft microdomains (~600–800 nm) on human T lymphoma cells, and disruption of membrane cholesterol with filipin or methyl-β-cyclodextrin disperses these clusters, establishing that CD48 resides in and requires intact lipid rafts for its membrane organisation.\",\n      \"method\": \"Immunogold electron microscopy; confocal microscopy; cholesterol depletion (filipin, methyl-β-cyclodextrin); cross-correlation analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences USA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — two orthogonal imaging methods with cholesterol depletion functional validation\",\n      \"pmids\": [\"10823948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"2B4/CD48 interactions regulate CD8+ T cell proliferation; blocking with anti-2B4 antibody reduces proliferative responses, and this occurs even in the absence of APCs, indicating that 2B4 on activated/memory T cells can serve as a ligand for CD48 on neighboring T cells to provide costimulatory-like function.\",\n      \"method\": \"Anti-2B4 and anti-CD48 blocking antibodies; T cell proliferation assay; APC-free cultures\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — antibody blocking with clear functional readout; single lab but mechanistically informative\",\n      \"pmids\": [\"11739483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Direct force measurements confirmed that full-length extracellular domains of murine CD2 and CD48 adhere in a head-to-head orientation, that the CD2-CD48 bond generates weak adhesion, and that lateral receptor mobility is required for appreciable adhesion.\",\n      \"method\": \"Surface force apparatus (direct force measurements between protein-coated surfaces)\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biophysical reconstitution directly measuring interaction distance-dependence and adhesion forces\",\n      \"pmids\": [\"12356317\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CD48 on mast cells mediates direct interaction with Mycobacterium tuberculosis: CD48 aggregates at sites of bacterial binding, and anti-CD48 antibodies inhibit mast cell histamine release in response to mycobacteria, indicating CD48 functions as a pattern recognition receptor for mycobacterial binding.\",\n      \"method\": \"Immunofluorescence microscopy (CD48 aggregation at bacterial binding sites); anti-CD48 antibody blockade; histamine release assay\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — localization with functional blockade, single lab\",\n      \"pmids\": [\"12759438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Homotypic 2B4/CD48 interactions among NK cells are essential for IL-2-driven NK cell expansion and activation; in the absence of 2B4/CD48 interaction (using gene-deficient cells and mAbs), NK cytotoxicity, IFN-γ secretion, and calcium signaling are severely impaired, and GFP-tagged 2B4 localises specifically to NK-NK conjugation sites.\",\n      \"method\": \"2B4-deficient NK cells; blocking mAbs; cytotoxicity assay; IFN-γ ELISA; calcium flux; GFP-2B4 live imaging of NK-NK conjugates; in vivo tumor clearance\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gene-deficient cells combined with live imaging and multiple functional readouts in vitro and in vivo\",\n      \"pmids\": [\"15905190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CD48 expression on dendritic cell subsets determines NK cell activation outcomes: monocyte-derived DCs and plasmacytoid DCs lack CD48, whereas blood/bone marrow myeloid DCs express it; NK cells are activated by CD48-expressing DCs but inhibited via 2B4 by CD48-expressing lymph node DCs, demonstrating that DC-subset-specific CD48 expression tunes 2B4-mediated NK activation or inhibition depending on anatomic context.\",\n      \"method\": \"Flow cytometry; NK:DC co-culture functional assays; IFN-γ production; NK cells from XLP patients (lacking SAP)\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — correlative expression combined with functional NK:DC co-culture assays including disease-validated (XLP) NK cells\",\n      \"pmids\": [\"16148114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CD48 interacts with IL-18Rα via both the peptide portion and the GPI glycan; IL-18Rα co-immunoprecipitates with CD48 from IL-18-stimulated KG-1 cells. Phospholipase C treatment removing GPI-anchored proteins (including CD48) inhibits IL-18-dependent tyrosine kinase phosphorylation and IFN-γ production, indicating the CD48/GPI glycan complex is required for IL-18 signaling.\",\n      \"method\": \"Co-immunoprecipitation; phosphatidylinositol-specific phospholipase C treatment; tyrosine phosphorylation assay; IFN-γ production\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus enzymatic removal of GPI proteins with functional readout; single lab\",\n      \"pmids\": [\"15760905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CD48 is an IL-3-upregulated activation receptor on human eosinophils; cross-linking CD48 on eosinophils triggers granule protein release (degranulation), and CD48 is induced by allergen challenge in a murine asthma model, establishing CD48 as a functional activating receptor on eosinophils.\",\n      \"method\": \"Flow cytometry; IL-3 stimulation; CD48 cross-linking degranulation assay; murine asthma model; anti-IL-3 treatment\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor cross-linking functional assay in primary cells plus in vivo model corroboration\",\n      \"pmids\": [\"16785501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GPI-anchored CD48 (but not CD59) is recruited to the immobilised TCR/CD3 complex upon T cell activation. CD48 reorganisation is required for IL-2 production by mediating lateral association of the adaptor LAT with the TCR/CD3 complex. CD2 acts hierarchically upstream, associating with TCR/CD3 irrespective of CD48 and recruiting CD48 and Lck; CD48 in turn shuttles LAT to the complex.\",\n      \"method\": \"Co-immunoprecipitation; siRNA knockdown of CD48; IL-2 production assay; sequential co-IP establishing CD2→CD48→LAT hierarchy\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with siRNA-mediated loss of function and clear IL-2 functional readout establishing pathway hierarchy\",\n      \"pmids\": [\"19494291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ORMDL3 overexpression in eosinophils regulates IL-3-induced expression of CD48, and CD48-mediated eosinophil degranulation; ORMDL3 knockdown inhibits CD48 surface expression as well as activation-induced cell shape changes and recruitment to inflammation, placing ORMDL3 upstream of CD48 in eosinophil activation.\",\n      \"method\": \"ORMDL3 overexpression/knockdown in eosinophils; flow cytometry; degranulation assay; in vivo recruitment assay\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain and loss of function with functional degranulation readout; single lab\",\n      \"pmids\": [\"24056518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CD48 on human and murine eosinophils directly binds Staphylococcus aureus and its exotoxins (SEB, protein A, peptidoglycan); SA/exotoxins enhance CD48 expression, aggregate at CD48 sites (confocal microscopy), and trigger eosinophil activation, degranulation, and cytokine release in a CD48-dependent manner confirmed in CD48-/- mouse bone marrow eosinophils.\",\n      \"method\": \"Confocal microscopy (CD48 aggregation at SA binding sites); blocking anti-CD48 antibody; CD48-/- mouse eosinophils; degranulation assay; cytokine ELISA; in vivo peritonitis model\",\n      \"journal\": \"Clinical and Experimental Allergy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO combined with multiple functional assays and in vivo model\",\n      \"pmids\": [\"25255823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A cytomegalovirus-encoded soluble CD48 homolog (A43) binds host 2B4 with high affinity and slow dissociation (surface plasmon resonance), abrogates host CD48:2B4 interactions, reduces NK cell-target conjugate formation, prevents immunological synapse establishment, and severely impairs 2B4-mediated NK cytotoxicity and IFN-γ production — establishing CD48:2B4 as required for NK effector function.\",\n      \"method\": \"Surface plasmon resonance; NK cytotoxicity assay; conjugate formation assay; IFN-γ measurement; viral protein functional characterisation\",\n      \"journal\": \"PLoS Pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — SPR quantitative binding combined with multiple independent NK functional assays\",\n      \"pmids\": [\"30947296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD48 expression in AML is regulated by DNA methylation; a hypomethylating agent increases CD48 expression on AML cells, restoring NK cell killing in vitro, and CD48 high expression reverses AML immune evasion and activates NK cell function in vivo.\",\n      \"method\": \"DNA methylation analysis; hypomethylating agent treatment; NK co-culture cytotoxicity assay; in vivo AML mouse model\",\n      \"journal\": \"Clinical Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epigenetic writer identified, in vitro and in vivo functional rescue demonstrated; single lab\",\n      \"pmids\": [\"31922199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD48 expression in human innate lymphoid cell precursors (ILCPs) modulates ILC differentiation: 2B4:CD48 interaction (between co-expressed 2B4 and CD48 on progenitors) specifically induces ILC2 differentiation in vitro, and CD48-expressing progenitors give rise to tissue-associated ILCs in vivo.\",\n      \"method\": \"In vitro progenitor differentiation assay; blocking antibodies against 2B4/CD48; in vivo xenograft (progenitor transfer); flow cytometry\",\n      \"journal\": \"Science Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor blocking plus in vivo transfer experiment; single lab\",\n      \"pmids\": [\"33219153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GDF15 binds CD48 on T cells as a previously unrecognised receptor; GDF15:CD48 interaction downregulates STUB1 (an E3 ubiquitin ligase that mediates FOXP3 degradation), thereby stabilising FOXP3, promoting iTreg generation and enhancing nTreg suppressive function. Co-immunoprecipitation confirmed GDF15-CD48 physical interaction.\",\n      \"method\": \"Co-immunoprecipitation; RNA sequencing; mass spectrometry; ChIP; flow cytometry; GDF15 KO mouse model; STUB1/FOXP3 protein stability assays\",\n      \"journal\": \"Journal for Immunotherapy of Cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — multiple orthogonal methods (co-IP, mass spec, ChIP, genetic KO, functional rescue) identifying novel receptor-ligand pair and downstream mechanism\",\n      \"pmids\": [\"34489334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Genome-wide CRISPR screen identified CD48 as the key determinant of ATLL cell susceptibility to NK cell-mediated cytotoxicity; CD48 knockout conferred resistance to NK killing, reduced IFN-γ induction and degranulation by primary NK cells, and primary ATLL cells showed reduced CD48 expression with disease progression.\",\n      \"method\": \"Genome-wide CRISPR knockout screen; primary NK cell cytotoxicity assay; IFN-γ and CD107a degranulation assays; flow cytometry of primary ATLL samples\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — unbiased genome-wide CRISPR screen with functional validation using primary NK cells and patient samples\",\n      \"pmids\": [\"35921533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HO-1 overexpression in AML cells specifically downregulates CD48 expression by directly interacting with Sirt1, increasing its deacetylase activity, leading to H3K27 deacetylation at the CD48 promoter to suppress CD48 transcription; Sirt1 inhibition restores CD48 expression, confirming the HO-1→Sirt1→H3K27 deacetylation→CD48 suppression axis.\",\n      \"method\": \"Co-immunoprecipitation (HO-1/Sirt1); Western blot; qRT-PCR; flow cytometry; Sirt1 inhibitor rescue; NK co-culture cytotoxicity; in vivo AML mouse model\",\n      \"journal\": \"Journal of Translational Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — co-IP establishing direct interaction, epigenetic mechanism validated with enzymatic inhibitor rescue, in vivo corroboration\",\n      \"pmids\": [\"36058936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"KDM6A (H3K27me3 demethylase) epigenetically regulates CD48 expression: KDM6A loss increases H3K27me3 on the CD48 promoter, markedly downregulating CD48, which contributes to resistance to daratumumab-mediated ADCC in multiple myeloma. EZH2 inhibitor treatment restores CD48 (and CD38) expression and reverses ADCC resistance.\",\n      \"method\": \"Genome-wide CRISPR screen; ChIP-seq (H3K27me3 at CD48 promoter); EZH2 inhibitor rescue; NK ADCC assay; flow cytometry\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — CRISPR screen, ChIP-seq mechanistic validation, pharmacological rescue with multiple functional readouts\",\n      \"pmids\": [\"38355622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"AML1-ETO fusion oncoprotein increases CD48 expression on AML cells through AML1-ETO/P300-mediated acetylation of CD48, inhibiting NK cell immune evasion; this provides a mechanism for the better clinical outcomes observed in AML1-ETO-positive AML.\",\n      \"method\": \"Immunoprecipitation; Western blot; flow cytometry; NK co-culture cytotoxicity assay\",\n      \"journal\": \"Leukemia and Lymphoma\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single-lab co-IP and functional assay identifying acetylation writer; moderate evidence\",\n      \"pmids\": [\"33225787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TGF-β downregulates CD48 surface expression on leukemia cells (MEG-01 and U937), reducing their susceptibility to NK-92MI killing and conjugate formation; CD48 knockdown phenocopies TGF-β treatment, confirming CD48 as the relevant target for TGF-β-mediated NK evasion of leukemia cells.\",\n      \"method\": \"TGF-β treatment; CD48 knockdown; NK co-culture cytotoxicity assay; conjugate formation assay; flow cytometry\",\n      \"journal\": \"Immunobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — cytokine treatment with genetic knockdown phenocopy; single lab\",\n      \"pmids\": [\"31421859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Occupancy of CD2 on mouse B cells by soluble recombinant mouse CD48 (its natural ligand) prevents antigen-induced apoptosis and upregulates Bcl-2 expression; anti-CD48 antibody abrogates allogeneic cell-induced clonal expansion, establishing that CD2-CD48 interaction controls B cell survival decisions.\",\n      \"method\": \"Soluble recombinant CD48 treatment; anti-CD48 blocking mAb; apoptosis (DNA fragmentation) assay; Bcl-2 Western blot\",\n      \"journal\": \"European Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — recombinant ligand plus blocking antibody with apoptosis and Bcl-2 molecular readout; single lab\",\n      \"pmids\": [\"7925579\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CD48 is a GPI-anchored cell-surface glycoprotein of the CD2/SLAM family that functions as a co-stimulatory adhesion and signaling molecule on hematopoietic cells: it interacts head-to-head with CD2 (via its membrane-distal Ig domain) to enhance TCR signaling by recruiting lipid rafts, LAT, and Lck to the TCR complex; it serves as the high-affinity ligand for 2B4 (CD244) on NK and T cells to regulate NK cytotoxicity, CD8+ T cell proliferation, and ILC differentiation; it acts as a receptor for GDF15 to stabilize FOXP3 in Tregs via STUB1 suppression; its surface expression is epigenetically controlled by KDM6A/EZH2 (H3K27me3), HO-1/Sirt1 (H3K27 deacetylation), and DNA methylation; and it mediates mast cell and eosinophil activation upon encounter with bacterial pathogens including M. tuberculosis and S. aureus.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CD48 is a GPI-anchored cell-surface glycoprotein of the CD2/SLAM family that functions as a multivalent co-stimulatory and adhesion molecule on hematopoietic cells, integrating signals that regulate T cell activation, NK cell cytotoxicity, innate lymphoid cell differentiation, and mast cell/eosinophil responses to bacterial pathogens. CD48 engages CD2 via a head-to-head interaction of its membrane-distal immunoglobulin domain with weak, rapidly dissociating affinity (~10⁴ M⁻¹), and this interaction enhances TCR signaling by recruiting CD48 into lipid raft microdomains where it shuttles the adaptor LAT and Lck to the TCR/CD3 complex in a CD2→CD48→LAT hierarchy [PMID:7697352, PMID:9881969, PMID:19494291]. CD48 also serves as the primary ligand for 2B4 (CD244), through which it triggers NK cell cytotoxicity, IFN-γ production, and CD8⁺ T cell proliferation, and homotypic 2B4–CD48 interactions on innate lymphoid cell precursors direct ILC2 differentiation [PMID:9834056, PMID:10359122, PMID:15905190, PMID:33219153]. CD48 surface expression is epigenetically controlled by H3K27 methylation/demethylation (KDM6A/EZH2) and H3K27 deacetylation (HO-1/Sirt1), and by DNA methylation, mechanisms exploited by tumor cells for NK immune evasion [PMID:38355622, PMID:36058936, PMID:31922199].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Before CD48's functional role was clear, demonstrating that soluble CD48 engagement of CD2 on B cells prevented antigen-induced apoptosis and upregulated Bcl-2 established that the CD2–CD48 axis delivers survival signals beyond simple adhesion.\",\n      \"evidence\": \"Soluble recombinant CD48 treatment of mouse B cells with apoptosis/Bcl-2 readouts and anti-CD48 blockade\",\n      \"pmids\": [\"7925579\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream signaling intermediates between CD2 engagement and Bcl-2 upregulation not identified\", \"Limited to B cells; generalizability to other lineages untested\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Identifying the CD2-binding site on the GFCC'C'' β-sheet of CD48's membrane-distal Ig domain through complementary charge-swap mutagenesis established the head-to-head topology of the CD2–CD48 complex spanning ~134 Å, defining the structural framework for all subsequent interaction studies.\",\n      \"evidence\": \"Complementary mutagenesis of rat CD2 and CD48 extracellular domains with structural modeling\",\n      \"pmids\": [\"7697352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution co-crystal structure at the time\", \"Rat system; human interface details inferred\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Single-molecule force measurements and SPR quantified the CD2–CD48 bond as weak and rapidly dissociating (~7.8 s⁻¹ off-rate, ~10⁴ M⁻¹ affinity), resolving how this interaction enables dynamic T cell scanning rather than stable adhesion.\",\n      \"evidence\": \"Flow chamber single-bond kinetics and surface plasmon resonance with purified rat CD2/CD48\",\n      \"pmids\": [\"8986773\", \"9188168\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Measurements performed with rat proteins; human kinetics not yet determined\", \"How weak affinity translates to functional signaling thresholds in vivo remained unclear\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Three concurrent advances established CD48's dual receptor partnerships and functional consequences: identification of 2B4 (CD244) as a second counter-receptor for CD48, demonstration that CD48 on APCs co-stimulates antigen-specific T cell activation via CD2, and the discovery that GPI-anchored CD48 enhances TCR signaling through lipid raft-dependent recruitment of TCR-ζ to the actin cytoskeleton.\",\n      \"evidence\": \"CD48-Ig fusion binding/IP identifying 2B4; CHO transfectant co-stimulation assays with anti-CD2 blockade; lipid raft fractionation and ζ-chain phosphorylation analysis\",\n      \"pmids\": [\"9834056\", \"9862369\", \"9881969\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of CD2 vs 2B4 engagement to downstream signaling not delineated\", \"Signaling intermediates between CD48 raft association and ζ phosphorylation unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"CD48 knockout mice showed severely impaired CD4⁺ T cell activation to mitogens, anti-CD3, and alloantigens, providing genetic proof that CD48 is required on both T cells and APCs for efficient TCR signaling in vivo.\",\n      \"evidence\": \"Gene-targeted CD48⁻/⁻ mice with T cell proliferation, MLR, and reciprocal cell-mixing experiments\",\n      \"pmids\": [\"9927686\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"NK cell phenotype in CD48⁻/⁻ mice not characterized in this study\", \"Whether CD48 loss affects thymic selection not addressed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that human 2B4 binds CD48 with high affinity and that CD48 engagement triggers NK cytotoxicity and IFN-γ production established the CD48–2B4 axis as a principal activating pathway for human NK cells.\",\n      \"evidence\": \"Soluble NAIL-Fc binding assay; NK cytotoxicity and IFN-γ measurement with CD48 protein and anti-2B4 mAb ligation\",\n      \"pmids\": [\"10359122\", \"10556801\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SAP-dependent vs SAP-independent signaling downstream of 2B4 not resolved\", \"Whether 2B4 can also deliver inhibitory signals (as later shown in XLP) not yet addressed\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Immunogold EM and confocal microscopy showed CD48 co-clusters with IL-2Rα and HLA in cholesterol-dependent lipid raft microdomains (~600–800 nm), and cholesterol depletion dispersed these clusters, establishing the biophysical basis for CD48's role as a raft-resident signaling organizer.\",\n      \"evidence\": \"Immunogold EM and confocal on T lymphoma cells; cholesterol depletion with filipin and methyl-β-cyclodextrin\",\n      \"pmids\": [\"10823948\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dynamic behavior of CD48 in rafts during active signaling not captured\", \"Whether CD48 itself nucleates raft assembly or is passively recruited unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Discovery that CD48 on mast cells directly binds Mycobacterium tuberculosis and mediates histamine release revealed an unexpected innate immune function for CD48 as a bacterial pattern recognition receptor, extending its role beyond lymphocyte co-stimulation.\",\n      \"evidence\": \"Confocal microscopy of CD48 aggregation at mycobacterial binding sites; anti-CD48 blockade of histamine release\",\n      \"pmids\": [\"12759438\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific mycobacterial ligand recognized by CD48 not identified\", \"Single lab; no independent confirmation at the time\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Multiple studies showed that homotypic 2B4–CD48 interactions among NK cells are essential for IL-2-driven NK expansion and that DC-subset-specific CD48 expression tunes whether 2B4 delivers activating or inhibitory signals, revealing context-dependent functional outcomes of the same receptor–ligand pair.\",\n      \"evidence\": \"2B4-deficient NK cells with cytotoxicity/calcium/IFN-γ readouts and GFP-2B4 live imaging; NK:DC co-culture with XLP patient NK cells\",\n      \"pmids\": [\"15905190\", \"16148114\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular switch between activating and inhibitory 2B4 signaling not fully resolved\", \"Role of SAP/EAT-2 adaptor balance in determining outcome not mechanistically dissected\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Co-immunoprecipitation of CD48 with IL-18Rα and the finding that GPI-anchor removal abolished IL-18-dependent tyrosine phosphorylation and IFN-γ production identified an unexpected role for CD48 in IL-18 receptor signaling, potentially through its GPI glycan.\",\n      \"evidence\": \"Co-IP from IL-18-stimulated KG-1 cells; phospholipase C treatment with functional readout\",\n      \"pmids\": [\"15760905\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"PLC treatment removes all GPI-anchored proteins, not just CD48\", \"No reciprocal validation or CD48-specific knockdown to confirm specificity\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Establishing the CD2→CD48→LAT signaling hierarchy at the TCR complex resolved how CD48 functions mechanistically as a molecular shuttle: CD2 first associates with TCR/CD3 and recruits CD48 and Lck, then CD48 brings LAT to the complex, which is required for IL-2 production.\",\n      \"evidence\": \"Sequential co-IP of TCR/CD3 complex components; CD48 siRNA knockdown with IL-2 functional readout in T cells\",\n      \"pmids\": [\"19494291\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How GPI-anchored CD48 (lacking cytoplasmic tail) physically associates with LAT not mechanistically explained\", \"Whether this hierarchy operates identically in CD8⁺ T cells not tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that CD48 on eosinophils directly binds Staphylococcus aureus and its exotoxins, triggering degranulation confirmed in CD48⁻/⁻ mice, consolidated CD48's role as a bacterial sensor on innate immune cells beyond mast cells.\",\n      \"evidence\": \"Confocal imaging, anti-CD48 blockade, CD48⁻/⁻ mouse eosinophils, in vivo peritonitis model\",\n      \"pmids\": [\"25255823\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular identity of the bacterial surface moiety recognized by CD48 still unknown\", \"Signaling pathway downstream of CD48 in eosinophils not characterized\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"A CMV-encoded soluble CD48 homolog (A43) that binds host 2B4 with high affinity and blocks NK immunological synapse formation provided evolutionary evidence that the CD48–2B4 axis is critical enough for antiviral immunity that viruses evolved a decoy to subvert it.\",\n      \"evidence\": \"SPR kinetics of viral A43–2B4 binding; NK conjugation, cytotoxicity, and IFN-γ assays\",\n      \"pmids\": [\"30947296\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo significance of A43 in CMV immune evasion not demonstrated\", \"Whether other viral CD48 mimics exist not surveyed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Multiple groups showed that DNA methylation and the AML1-ETO/P300 axis regulate CD48 expression in leukemia, with hypomethylating agents or AML1-ETO restoring CD48 and NK killing, linking CD48 epigenetic silencing to tumor immune evasion.\",\n      \"evidence\": \"DNA methylation analysis with HMA treatment; AML1-ETO/P300 co-IP; NK co-culture cytotoxicity in vitro and in vivo AML models\",\n      \"pmids\": [\"31922199\", \"33225787\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether DNA methylation and histone modifications cooperate at the CD48 locus not addressed\", \"Patient-level correlation between CD48 methylation and clinical outcome limited\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Discovery that 2B4–CD48 interactions on innate lymphoid cell precursors direct ILC2 differentiation extended CD48's functional repertoire from mature effector cell co-stimulation to lineage specification of innate lymphoid cells.\",\n      \"evidence\": \"In vitro ILCP differentiation with 2B4/CD48 blocking antibodies; in vivo xenograft progenitor transfer\",\n      \"pmids\": [\"33219153\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream transcriptional program linking 2B4/CD48 to ILC2 commitment not identified\", \"Single lab; independent replication lacking\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying GDF15 as a novel ligand for CD48 that stabilizes FOXP3 by suppressing STUB1-mediated ubiquitination revealed a previously unknown receptor function for CD48 in regulatory T cell biology, distinct from its CD2/2B4-binding roles.\",\n      \"evidence\": \"Co-IP, mass spectrometry, ChIP, RNA-seq, GDF15 KO mice, STUB1/FOXP3 protein stability assays\",\n      \"pmids\": [\"34489334\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding interface between GDF15 and CD48 not structurally characterized\", \"Whether GDF15–CD48 competes with CD2 or 2B4 binding not determined\", \"Downstream signaling from GPI-anchored CD48 to STUB1 suppression unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Convergent CRISPR screens and epigenetic dissection established that KDM6A demethylase maintains CD48 expression via H3K27me3 removal at the CD48 promoter, while HO-1/Sirt1-mediated H3K27 deacetylation suppresses it, defining a dual epigenetic rheostat controlling CD48-dependent immune recognition of tumor cells.\",\n      \"evidence\": \"Genome-wide CRISPR screens in ATLL and myeloma; ChIP-seq for H3K27me3; HO-1/Sirt1 co-IP; EZH2 and Sirt1 inhibitor rescue; NK ADCC and cytotoxicity assays\",\n      \"pmids\": [\"35921533\", \"36058936\", \"38355622\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between KDM6A/EZH2 axis and HO-1/Sirt1 axis at the same locus not examined\", \"Whether these epigenetic mechanisms are tumor-type-specific or general remains untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis of the GDF15–CD48 interaction, how GPI-anchored CD48 (lacking a cytoplasmic domain) transduces intracellular signals to LAT or STUB1, the identity of bacterial surface moieties recognized by CD48, and whether the multiple epigenetic control mechanisms converge on a unified chromatin state at the CD48 locus.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No co-crystal structure of CD48 with any of its ligands\", \"Signaling mechanism from GPI-anchor to intracellular effectors undefined\", \"Bacterial ligands for CD48 unidentified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 4, 5, 7, 16]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [3, 6, 22]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [3, 6, 12, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 4, 8, 16]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4, 6, 7, 12, 18, 19, 23]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 16, 22]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CD2\",\n      \"CD244\",\n      \"LAT\",\n      \"LCK\",\n      \"GDF15\",\n      \"IL18R1\",\n      \"SIRT1\",\n      \"HMOX1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}